Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments

NEXT STORY
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
PREV STORY
Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Marinus Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial for Ganaxolone IV

RADNOR, Pa., June 22, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Apricus Biosciences Announces Corporate Update and Second Quarter 2017 Financial Results Conference Call

SAN DIEGO, July 26, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Akebia Announces Presentations at the Upcoming American Society of Nephrology Kidney Week 2015 Annual Meeting

CAMBRIDGE, Mass., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical ...

author_avatar
NASDAQ Market News